Holen Sie sich die Stockscreener-App
0.50
1.42%
-0.008
Schlusskurs vom Vortag:
$0.508
Offen:
$0.5078
24-Stunden-Volumen:
25,882
Relative Volume:
0.04
Marktkapitalisierung:
$48.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-102.09M
KGV:
-0.9009
EPS:
-0.555
Netto-Cashflow:
$-108.72M
1W Leistung:
-10.57%
1M Leistung:
-28.56%
6M Leistung:
-59.02%
1J Leistung:
-69.09%
1-Tages-Spanne:
$0.4753
$0.5078
1-Wochen-Bereich:
$0.4409
$0.609
52-Wochen-Spanne:
$0.4409
$2.14
Dbv Technologies Adr Stock (DBVT) Company Profile
Firmenname
Dbv Technologies Adr
Sektor
Branche
Telefon
33(0)155427878
Adresse
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Vergleichen Sie DBVT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| DBVT | 0.50 | 48.01M | 0 | -102.09M | -108.72M | -0.555 |
| VRTX | 450.44 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.45 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.18 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.35 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.90 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-04 | Hochstufung | Societe Generale | Hold → Buy |
| 2022-12-16 | Herabstufung | Goldman | Neutral → Sell |
| 2022-05-10 | Herabstufung | Goldman | Buy → Neutral |
| 2021-09-14 | Hochstufung | Societe Generale | Hold → Buy |
| 2021-01-22 | Herabstufung | Societe Generale | Hold → Sell |
| 2020-11-02 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-08-06 | Herabstufung | Societe Generale | Buy → Sell |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-17 | Herabstufung | Stifel | Buy → Hold |
| 2020-01-09 | Hochstufung | Stifel | Hold → Buy |
| 2019-12-16 | Eingeleitet | Citigroup | Buy |
| 2019-09-05 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-06-17 | Eingeleitet | Goldman | Buy |
| 2018-12-20 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-12-20 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2018-12-20 | Herabstufung | Jefferies | Buy → Hold |
| 2018-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2017-10-31 | Hochstufung | Societe Generale | Sell → Hold |
| 2017-10-24 | Herabstufung | Societe Generale | Buy → Sell |
| 2017-10-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2017-06-23 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-16 | Hochstufung | Societe Generale | Hold → Buy |
| 2016-09-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-03 | Eingeleitet | Barclays | Overweight |
| 2015-10-23 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Dbv Technologies Adr Aktie (DBVT) Neueste Nachrichten
DBV Technologies (STU:DBV0) Shares Outstanding (EOP) : 96.20 Mil (As of Sep. 2024) - GuruFocus.com
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower - MSN
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading - MSN
European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week - MSN
European Equities Traded in the US as American Depositary Rise Thursday - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - MSN
StockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World
DBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
DBV Technologies Stock to Reverse Split on Friday, November 29th (NASDAQ:DBVT) - Defense World
DBV Technologies Stock Set to Reverse Split on Friday, November 29th (NASDAQ:DBVT) - MarketBeat
DBV Technologies Announces Plan to Implement ADS Ratio Change - The Manila Times
DBV Technologies Plans 1:5 ADS Ratio Change to Meet Nasdaq Requirements | DBVT Stock News - StockTitan
DBV Technologies’ stock slides as financial woes worsens - Pharmaceutical Technology
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - MSN
DBV Technologies Reports Third Quarter 2024 Financial Results - GlobeNewswire
DBV Technologies (NASDAQ:DBVT) Stock Price Passes Above 50 Day Moving AverageTime to Sell? - MarketBeat
DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - Defense World
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - MSN
DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World
DBV Technologies (NASDAQ:DBVT) Receives New Coverage from Analysts at StockNews.com - MarketBeat
European Equities Traded in the US as American Depositary Receipts Gain Wednesday - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - MSN
HC Wainwright Forecasts Higher Earnings for DBV Technologies - Defense World
European Equities Traded in the US as American Depositary Receipts Rise Slightly Higher in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN
Data-Based Insights About DBV Technologies ADR (DBVT) - Stocks Register
HC Wainwright Has Positive Forecast for DBVT FY2024 Earnings - MarketBeat
GSK Plc ADR (GSK): An Important Analyst Insights - Stocks Register
Paramount Global (NASDAQ: PARA): Blank Check On Growth? - Stocks Register
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading - MSN
H.C. Wainwright raises DBV Technologies shares price target, keeps Buy rating - Investing.com India
DBV Technologies (NASDAQ:DBVT) PT Raised to $7.00 - MarketBeat
The United States Allergy Immunotherapy Market Size & Outlook, 2027 - Grand View Research
DBV Technologies ADR (NASDAQ: DBVT) Is The Number One Stock Currently Moving. - Stocks Register
Atlantic Union Bankshares Corp Still Hasn’t Convinced Analysts? - Stocks Register
H.C. Wainwright & Co. Raises Price Target on Biotech Following Positive Regulatory Updates - Streetwise Reports
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe - GlobeNewswire
DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.com - Defense World
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress - The Manila Times
DBV Technologies S.A. - Via Ritzau
Peanut Protein Patch Market Report to 2032 -DBV Technologies, Segment - IndiaPolitics.com
Finanzdaten der Dbv Technologies Adr-Aktie (DBVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dbv Technologies Adr-Aktie (DBVT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mohideen Pharis | Chief Medical Officer |
May 24 '24 |
Sale |
1.36 |
660 |
898 |
81,152 |
| Mohideen Pharis | Chief Medical Officer |
May 22 '24 |
Sale |
1.38 |
382 |
527 |
81,812 |
| Tasse Daniel | CHIEF EXECUTIVE OFFICER |
Mar 08 '24 |
Buy |
0.83 |
17,094 |
14,188 |
17,094 |
| Ndu Adora | Director |
Feb 06 '24 |
Buy |
0.89 |
1,825 |
1,624 |
1,825 |
| Mohideen Pharis | Chief Medical Officer |
Nov 22 '23 |
Sale |
1.74 |
2,245 |
3,906 |
82,194 |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):